Garces YI, Yang P, Parkinson J, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest. 2004;126(6):1733–41. https://doi.org/10.1378/chest.126.6.1733.
Gritz ER, Toll BA, Warren GW. Tobacco use in the oncology setting: advancing clinical practice and research. Cancer Epidemiology, Biomarkers & Prevention. 2014;23(1):3–9. https://doi.org/10.1158/1055-9965.EPI-13-0896.
Park ER, Japuntich SJ, Rigotti NA, et al. A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer. 2012;118(12):3153–64. https://doi.org/10.1002/cncr.26545.
Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol. 2005;23(34):8884–93. https://doi.org/10.1200/JCO.2005.02.2343.
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Centers for Disease Control and Prevention (US); 2014. Accessed 28 Dec 2021. http://www.ncbi.nlm.nih.gov/books/NBK179276/
Garces YI, Schroeder DR, Nirelli LM, et al. Second primary tumors following tobacco dependence treatments among head and neck cancer patients. Am J Clin Oncol. 2007;30(5):531–9. https://doi.org/10.1097/COC.0b013e318059adfc.
Richardson GE, Tucker MA, Venzon DJ, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med. 1993;119(5):383–90. https://doi.org/10.7326/0003-4819-119-5-199309010-00006.
Tucker MA, Murray N, Shaw EG, et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst. 1997;89(23):1782–8. https://doi.org/10.1093/jnci/89.23.1782.
Joshu CE, Mondul AM, Meinhold CL, et al. Cigarette smoking and prostate cancer recurrence after prostatectomy. J Natl Cancer Inst. 2011;103(10):835–8. https://doi.org/10.1093/jnci/djr124.
Fleshner N, Garland J, Moadel A, et al. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer. 1999;86(11):2337–45.
Rice D, Kim HW, Sabichi A, et al. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2003;76(4):1001–7. https://doi.org/10.1016/s0003-4975(03)00821-xdiscussion 1007-1008.
Do KA, Johnson MM, Doherty DA, et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control. 2003;14(2):131–8. https://doi.org/10.1023/a:1023060315781.
Dresler CM. Is it more important to quit smoking than which chemotherapy is used? Lung Cancer. 2003;39(2):119–24. https://doi.org/10.1016/s0169-5002(02)00455-5.
Shen T, Le W, Yee A, Kamdar O, Hwang PH, Upadhyay D. Nicotine induces resistance to chemotherapy in nasal epithelial cancer. Am J Rhinol Allergy. 2010;24(2):e73-77. https://doi.org/10.2500/ajra.2010.24.3456.
Chen AM, Chen LM, Vaughan A, et al. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys. 2011;79(2):414–9. https://doi.org/10.1016/j.ijrobp.2009.10.050.
Kelemen LE, Warren GW, Koziak JM, Köbel M, Steed H. Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer. Gynecol Oncol. 2016;140(1):124–30. https://doi.org/10.1016/j.ygyno.2015.11.008.
Jung KH, Kim SM, Choi MG, et al. Preoperative smoking cessation can reduce postoperative complications in gastric cancer surgery. Gastric Cancer. 2015;18(4):683–90. https://doi.org/10.1007/s10120-014-0415-6.
Zhang J, Kamdar O, Le W, Rosen GD, Upadhyay D. Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am J Respir Cell Mol Biol. 2009;40(2):135–46. https://doi.org/10.1165/rcmb.2007-0277OC.
Xu J, Huang H, Pan C, Zhang B, Liu X, Zhang L. Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells. Int J Oral Maxillofac Surg. 2007;36(8):739–44. https://doi.org/10.1016/j.ijom.2007.05.016.
Daniel M, Keefe FJ, Lyna P, et al. Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels. J Pain. 2009;10(3):323–8. https://doi.org/10.1016/j.jpain.2008.10.006.
Danson SJ, Rowland C, Rowe R, et al. The relationship between smoking and quality of life in advanced lung cancer patients: a prospective longitudinal study. Support Care Cancer. 2016;24(4):1507–16. https://doi.org/10.1007/s00520-015-2928-x.
Gritz ER, Nisenbaum R, Elashoff RE, Holmes EC. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control. 1991;2(2):105–12. https://doi.org/10.1007/BF00053129.
Dresler CM, Bailey M, Roper CR, Patterson GA, Cooper JD. Smoking cessation and lung cancer resection. Chest. 1996;110(5):1199–202. https://doi.org/10.1378/chest.110.5.1199.
Sanderson Cox L, Patten CA, Ebbert JO, et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. J Clin Oncol. 2002;20(16):3461–9. https://doi.org/10.1200/JCO.2002.10.085.
Schnoll RA, Zhang B, Rue M, et al. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the eastern cooperative oncology group. JCO. 2003;21(2):355–65. https://doi.org/10.1200/JCO.2003.04.122.
Shields PG, Herbst RS, Arenberg D, et al. Smoking cessation, version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14(11):1430–68. https://doi.org/10.6004/jnccn.2016.0152.
Warren GW, Marshall JR, Cummings KM, et al. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thorac Oncol. 2013;8(5):543–8. https://doi.org/10.1097/JTO.0b013e318288dc96.
Warren GW, Marshall JR, Cummings KM, et al. Addressing tobacco use in patients with cancer: a survey of american society of clinical oncology members. J Oncol Pract. 2013;9(5):258–62. https://doi.org/10.1200/JOP.2013.001025.
Park ER, Perez GK, Rigotti NA, et al. Tobacco assistance for recently diagnosed cancer patients: who does not receive assistance? Orlando: Presented at: Presentation as part of a symposium to the 14th Annual Meeting of the American Psychosocial Oncology Society; 2017.
Park ER, Perez GK, Regan S, et al. Effect of sustained smoking cessation counseling and provision of medication vs shorter-term counseling and medication advice on smoking abstinence in patients recently diagnosed with cancer: a randomized clinical trial. JAMA. 2020;324(14):1406–18. https://doi.org/10.1001/jama.2020.14581.
Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs. Med Care. 2012;50(3):217–26. https://doi.org/10.1097/MLR.0b013e3182408812.
Browning KK, Wewers ME, Ferketich AK, Otterson GA, Reynolds NR. The self-regulation model of illness applied to smoking behavior in lung cancer. Cancer Nurs. 2009;32(4):E15–25. https://doi.org/10.1097/NCC.0b013e3181a0238f.
Jones CL, Jensen JD, Scherr CL, Brown NR, Christy K, Weaver J. The health belief model as an explanatory framework in communication research: exploring parallel, serial, and moderated mediation. Health Commun. 2015;30(6):566–76. https://doi.org/10.1080/10410236.2013.873363.
Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76. https://doi.org/10.1007/s10488-010-0319-7.
Weiner BJ, Lewis CC, Stanick C, et al. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017;12(1):108. https://doi.org/10.1186/s13012-017-0635-3.
Shea CM, Jacobs SR, Esserman DA, Bruce K, Weiner BJ. Organizational readiness for implementing change: a psychometric assessment of a new measure. Implement Sci. 2014;9:7. https://doi.org/10.1186/1748-5908-9-7.
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. https://doi.org/10.1186/1748-5908-4-50.
Neil JM, Senecal C, Ballini L, et al. A multimethod evaluation of tobacco treatment trial recruitment messages for current smokers recently diagnosed with cancer: pilot factorial randomized controlled trial. JMIR Cancer. In press.
Miller WR, Rollnick S. Motivational Interviewing: Helping People for Change. New York: Guilford Press; 2012.
Fiore MC, Jaen C, Baker T, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF, Froelicher EF, Goldstein MG, Healton CG, Henderson PN. Treating Tobacco Use and Dependence: 2008 Update Clinical Practice Guideline. Department of Health and Human Services. Rockville: Public Health Service; 2008.
Park ER, Ostroff JS, Perez GK, et al. Integrating tobacco treatment into cancer care: study protocol for a randomized controlled comparative effectiveness trial. Contemp Clin Trials. 2016;50:54–65. https://doi.org/10.1016/j.cct.2016.07.016.
Land SR, Toll BA, Moinpour CM, et al. Research priorities, measures, and recommendations for assessment of tobacco use in clinical cancer research. Clin Cancer Res. 2016;22(8):1907–13. https://doi.org/10.1158/1078-0432.CCR-16-0104.
Piper ME, Bullen C, Krishnan-Sarin S, et al. Defining and measuring abstinence in clinical trials of smoking cessation interventions: an updated review. Nicotine Tob Res. 2020;22(7):1098–106. https://doi.org/10.1093/ntr/ntz110.
Montalto NJ, Wells WO. Validation of self-reported smoking status using saliva cotinine: a rapid semiquantitative dipstick method. Cancer Epidemiol Biomarkers Prev. 2007;16(9):1858–62. https://doi.org/10.1158/1055-9965.EPI-07-0189.
Park ER, Kirchhoff AC, Nipp RD, et al. Assessing health insurance coverage characteristics and impact on health care cost, worry, and access. JAMA Intern Med. 2017;177(12):1855–8. https://doi.org/10.1001/jamainternmed.2017.5047.
Land SR, Warren GW, Crafts JL, et al. Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical research. Cancer. 2016;122(11):1728–34. https://doi.org/10.1002/cncr.29964.
Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791–9. https://doi.org/10.1111/j.1360-0443.1989.tb03059.x.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The fagerström test for nicotine dependence: a revision of the fagerström tolerance questionnaire. Br J Addict. 1991;86(9):1119–27. https://doi.org/10.1111/j.1360-0443.1991.tb01879.x.
Pérez-Ríos M, Santiago-Pérez M, Alonso B, Malvar A, Hervada X, de Leon J. Fagerstrom test for nicotine dependence vs heavy smoking index in a general population survey. BMC Public Health. 2009;9(1):493. https://doi.org/10.1186/1471-2458-9-493.
Frank D, DeBenedetti AF, Volk RJ, Williams EC, Kivlahan DR, Bradley KA. Effectiveness of the AUDIT-C as a screening test for alcohol misuse in three race/ethnic groups. J Gen Intern Med. 2008;23(6):781–7. https://doi.org/10.1007/s11606-008-0594-0.
Holland JC, Andersen B, Breitbart WS, et al. Distress management. J Natl Compr Canc Netw. 2013;11(2):190–209. https://doi.org/10.6004/jnccn.2013.0027.
Piriz IE, Ferro NE, Di Pretoro M, et al. Distress in oncology patients: distress thermometer in a Latin American study. JCO. 2005;23(16_suppl):8211–8211. https://doi.org/10.1200/jco.2005.23.16_suppl.8211.
Intro to PROMIS. Accessed 28 Dec 2021. https://www.healthmeasures.net/explore-measurement-systems/promis/intro-to-promis
Reeve BB, Hays RD, Bjorner JB, et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5 Suppl 1):S22-31. https://doi.org/10.1097/01.mlr.0000250483.85507.04.
Hamann HA, Ostroff JS, Marks EG, Gerber DE, Schiller JH, Lee SJC. Stigma among patients with lung cancer: a patient-reported measurement model. Psychooncology. 2014;23(1):81–92. https://doi.org/10.1002/pon.3371.
Hamann HA, Shen MJ, Thomas AJ, Craddock Lee SJ, Ostroff JS. Development and preliminary psychometric evaluation of a patient-reported outcome measure for lung cancer stigma: The Lung Cancer Stigma Inventory (LCSI). Stigma Health. 2018;3(3):195–203. https://doi.org/10.1037/sah0000089.
Etter JF, Perneger TV. Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public. Clin Pharmacol Ther. 2001;69(3):175–83. https://doi.org/10.1067/mcp.2001.113722.
Park ER, Ostroff JS, Rakowski W, et al. Risk perceptions among participants undergoing lung cancer screening: baseline results from the National Lung Screening Trial. Ann Behav Med. 2009;37(3):268–79. https://doi.org/10.1007/s12160-009-9112-9.
Stuber J, Galea S, Link BG. Smoking and the emergence of a stigmatized social status. Soc Sci Med. 2008;67(3):420–30. https://doi.org/10.1016/j.socscimed.2008.03.010.
West R, Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology. 2004;177(1–2):195–9. https://doi.org/10.1007/s00213-004-1923-6.
Adult National Social Climate of Tobacco Control Survey Reports. Accessed 28 Dec 2021. https://www.socialclimate.org/publications-social-climate-tobacco-control/reports-on-social-climate-tobacco-control/
Hahn EA, DeWalt DA, Bode RK, et al. New English and Spanish social health measures will facilitate evaluating health determinants. Health Psychol. 2014;33(5):490–9. https://doi.org/10.1037/hea0000055.
Hayden D, Pauler DK, Schoenfeld D. An estimator for treatment comparisons among survivors in randomized trials. Biometrics. 2005;61(1):305–10. https://doi.org/10.1111/j.0006-341X.2005.030227.x.
Rubin D. 1987. Multiple Imputation for Nonresponse in Surveys. John Wiley & Sons, Inc. https://doi.org/10.1002/9780470316696.fmatter
Schnoll RA, Goelz PM, Veluz-Wilkins A, et al. Long-term nicotine replacement therapy: a randomized clinical trial. JAMA Intern Med. 2015;175(4):504–11. https://doi.org/10.1001/jamainternmed.2014.8313.
Gold M, Siegel J, Russell L, Weinstein M. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
QSR International Pty Ltd. (2018) NVivo (Version 12), https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home
Simmons VN, Litvin EB, Patel RD, et al. Patient-provider communication and perspectives on smoking cessation and relapse in the oncology setting. Patient Educ Couns. 2009;77(3):398–403. https://doi.org/10.1016/j.pec.2009.09.024.
Burke L, Miller LA, Saad A, Abraham J. Smoking behaviors among cancer survivors: an observational clinical study. J Oncol Pract. 2009;5(1):6–9. https://doi.org/10.1200/JOP.0912001.
Bjurlin MA, Goble SM, Hollowell CMP. Smoking cessation assistance for patients with bladder CFancer: a national survey of American urologists. J Urol. 2010;184(5):1901–6. https://doi.org/10.1016/j.juro.2010.06.140.
Weaver KE, Danhauer SC, Tooze JA, et al. Smoking cessation counseling beliefs and behaviors of outpatient oncology providers. Oncologist. 2012;17(3):455–62. https://doi.org/10.1634/theoncologist.2011-0350.
Simmons VN, Litvin EB, Unrod M, Brandon TH. Oncology healthcare providers’ implementation of the 5 A’s model of brief intervention for smoking cessation: patients’ perceptions. Patient Educ Couns. 2012;86(3):414–9. https://doi.org/10.1016/j.pec.2011.06.016F.
The Cancer Center Cessation Initiative Telehealth Working Group. Telehealth delivery of tobacco cessation treatment in cancer care: an ongoing innovation accelerated by the COVID-19 pandemic. J Natl Compr Cancer Netw. 2021;19(Suppl_1):S21–4. https://doi.org/10.6004/jnccn.2021.7092.